europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

16/03/2023
PRESS RELEASE

Brussels, 16 March 2023 – Visionary policy, urgency, a clear voice from industry, and enabling regulation for biomanufacturing were the key takeaways from EuropaBio’s first Biomanufacturing Policy Summit, hosted on March 15 in Brussels.

Over 75 EuropaBio members and guests from across the biomanufacturing spectrum came together to discuss Europe in global terms – how to make the most of its advantages and address the critical points that slow its progress compared to other parts of the world.

The meeting kick-started by setting the scene – Europe’s ambition, led by RTD’s Peter Dröll, followed by a look inside the White House Executive Order with BIO’s Hilary Stiss and biopharma manufacturing as a measure of Europe’s competitiveness, with Wojciech Nowak of Novartis. ‘I am Biomanufacturing’ saw three faces of biomanufacturing, with Evonik’s walk through the everyday products in our life that are the changing origins of chemicals, SwiftPharma moving the needle on plant-manufactured drugs, and Belgium showing how it’s done in building the ecosystem for success.

Delegates got to work debating where Europe should be in 10 years for biomanufacturing, why it’s important, and what are the incentives and obstacles on the way. The afternoon wrapped with a panel discussion moderated by GROW’s Kristin Schreiber, with panelists Peter Wehrheim of RTD, Kristin Thompson of investor EUREKARE, Nessa Fennelly of Ireland’s Ibec, Nicolo Giacomuzzi-Moore of CBE JU and Stefaan Fiers of Takeda Belgium. A level playing field for the much-needed transition to sustainably produced products was a key point plus the need for serious communication with consumers and investment into the skills to deliver. Finally, the day closed with the question to all on whether Europe wants to be the pilot or the passenger on the world’s transition into a biomanufacturing powerhouse, a message that EuropaBio takes into its vision for Biomanufacturing Platform delivery over the coming year.

Claire Skentelbery, EuropaBio DG commented “Yesterday saw a first step in the recognition of the value and impact of biomanufacturing and Europe’s essential journey for industrial transformation. The diversity of delegates showed the role for multiple actors, united by their ambition for what Europe can achieve.”

Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders


Read more
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?


Read more
03/03/2023

For The Love of Science


Read more
01/03/2023

Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies